Quick Comparison
| Citicoline (CDP-Choline) | Uridine | |
|---|---|---|
| Half-Life | 56-71 hours (sustained release characteristics) | 2-5 hours |
| Typical Dosage | Standard: 250-500 mg daily. Clinical studies use 500-2000 mg daily. Take in the morning — mildly stimulating. Cognizin is the most studied form. Can be split into 2 doses. Often combined with racetams to provide the choline needed for enhanced acetylcholine turnover. | Standard: 150-250 mg Uridine Monophosphate sublingually or orally, twice daily. Best combined with fish oil (DHA) and a choline source for the full 'Mr. Happy Stack' protocol. |
| Administration | Oral (capsules, powder). Cognizin branded form is most studied. Take in the morning. | Sublingual or oral. Uridine monophosphate is the preferred form. Triacetyluridine (TAU) is a more bioavailable prodrug. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
Citicoline (CDP-Choline)
Citicoline (CDP-choline) is hydrolyzed in the gut by alkaline phosphatase to choline and cytidine-5'-monophosphate, which are absorbed separately and reassembled in the brain via the Kennedy pathway. Choline feeds two critical pathways: (1) Acetylcholine synthesis via choline acetyltransferase (ChAT) — the primary memory and learning neurotransmitter acting at muscarinic and nicotinic receptors. (2) Phosphatidylcholine synthesis via CTP:phosphocholine cytidylyltransferase — the structural component of neuronal membranes and synaptic vesicles. Cytidine is dephosphorylated to uridine, converted to UTP, and supports RNA synthesis and CDP-choline formation for synapse formation. Citicoline also activates SIRT1 (possibly via NAD+ modulation) and increases brain norepinephrine and dopamine (mechanism unclear — may enhance synthesis or release). It is the only choline source providing both cholinergic and membrane-building support in one molecule.
Uridine
Uridine (as UMP) is phosphorylated to UTP and enters the Kennedy pathway, where it combines with choline via CTP:phosphocholine cytidylyltransferase to form CDP-choline — the rate-limiting step in phosphatidylcholine synthesis. Uridine provides the nucleotide component needed for constructing phosphatidylcholine in neuronal cell membranes and synaptic vesicles. Uridine stimulates neurite outgrowth and synaptogenesis via activation of P2Y receptors and downstream PI3K/Akt signaling. It upregulates dopamine D2 receptor expression in the striatum and enhances dopaminergic neurotransmission. When combined with DHA (from fish oil) and choline, the three compounds synergistically increase synaptic membrane synthesis, dendritic spine density, and dopaminergic signaling — the 'Mr. Happy Stack' mechanism.
Risks & Safety
Citicoline (CDP-Choline)
Common
Headache (especially with racetams — indicates too much cholinergic stimulation), nausea, diarrhea.
Serious
None documented at standard doses.
Rare
Insomnia, blurred vision.
Uridine
Common
Mild gastrointestinal discomfort, diarrhea.
Serious
Very limited long-term human supplementation data.
Rare
Lethargy, vivid dreams, depressive symptoms in some users.
Full Profiles
Citicoline (CDP-Choline) →
A naturally occurring intermediate in the synthesis of phosphatidylcholine, the primary phospholipid in neuronal cell membranes. Citicoline provides both choline (for acetylcholine and phospholipid synthesis) and cytidine (converted to uridine, supporting RNA and synapse formation). It is prescribed in Europe and Japan for stroke recovery and cognitive decline. Cognizin is the most studied branded form.
Uridine →
A nucleotide base that plays a critical role in brain cell membrane synthesis, synapse formation, and dopamine receptor expression. Part of the well-known 'Mr. Happy Stack' (Uridine + Fish Oil + Choline) that synergistically supports mood and cognitive function. Uridine monophosphate is the preferred supplemental form for brain bioavailability.